NI
GMED icon

Nuance Investments’s Globus Medical GMED Stock Holding History

Nuance Investments’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,620,518
Closed -$180M – 53
2023
Q3 		$180M Buy
3,620,518
+974,693
+37% +$54.5M 4.4% 7
2023
Q2 		$158M Buy
2,645,825
+799,526
+43% +$45.6M 3.37% 11
2023
Q1 		$105M Buy
1,846,299
+1,834,444
+15,474% +$118M 2.22% 15
2022
Q4 		$880K Buy
11,855
+3,369
+40% +$229K 0.02% 52
2022
Q3 		$506K Buy
8,486
+4,769
+128% +$287K 0.01% 52
2022
Q2 		$209K Buy
+3,717
New +$244K ﹤0.01% 52
2021
Q3 		– Sell
-217,419
Closed -$16.9M – 58
2021
Q2 		$16.9M Sell
217,419
-268,906
-55% -$19.1M 0.3% 41
2021
Q1 		$30M Buy
486,325
+317,200
+188% +$20.1M 0.56% 34
2020
Q4 		$11M Sell
169,125
-905,829
-84% -$52.1M 0.21% 50
2020
Q3 		$53.2M Sell
1,074,954
-108,205
-9% -$5.58M 1.25% 22
2020
Q2 		$56.4M Sell
1,183,159
-363,170
-23% -$17.5M 1.46% 23
2020
Q1 		$65.8M Buy
1,546,329
+1,416,698
+1,093% +$70M 2.28% 17
2019
Q4 		$7.64M Sell
129,631
-736,241
-85% -$40M 0.25% 41
2019
Q3 		$44.3M Sell
865,872
-450,185
-34% -$21.4M 1.67% 21
2019
Q2 		$55.7M Buy
1,316,057
+993,056
+307% +$43.1M 2.36% 19
2019
Q1 		$16M Buy
323,001
+198,385
+159% +$8.97M 0.83% 34
2018
Q4 		$5.39M Buy
124,616
+119,399
+2,289% +$5.96M 0.36% 48
2018
Q3 		$296K Buy
5,217
+531
+11% +$27.9K 0.02% 59
2018
Q2 		$236K Buy
+4,686
New +$244K 0.02% 58
2018
Q1 		– Sell
-98,439
Closed -$4.05M – 60
2017
Q4 		$4.05M Sell
98,439
-678,480
-87% -$23.8M 0.27% 54
2017
Q3 		$23.1M Buy
776,919
+524,248
+207% +$16M 1.6% 23
2017
Q2 		$8.38M Sell
252,671
-562,382
-69% -$17.7M 0.63% 30
2017
Q1 		$24.1M Sell
815,053
-151,436
-16% -$4.13M 1.89% 18
2016
Q4 		$24M Buy
+966,489
New +$22M 2.01% 17

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuance Investments's GMED Position: Q4 2023 in Review

Nuance Investments sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 3,620,518 shares — an estimated $180M sold.

Nuance Investments first reported a position in GMED in Q4 2016 and held it in 24 quarters. The position peaked at $180M in Q3 2023. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

  • Nuance Investments reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
  • Nuance Investments sold 3,620,518 Globus Medical shares in Q4 2023, an estimated $180M.
  • Nuance Investments first reported a position in Globus Medical in Q4 2016 and held it in 24 quarters.
  • Nuance Investments's Globus Medical position peaked at $180M in Q3 2023.
  • 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Nuance Investments's 13F filing for Q4 2023, filed 7 Feb 2024.